Skip to main content

​Recent biotech IPOs get fewer new investors than it appears, says report

The biotechs that have gone public so far this year, most of which have been in Massachusetts, have attracted far fewer new investors than it might seem, leading IPO analysts at Renaissance Capital to go so far as to call them “quasi-IPOs...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.